[go: up one dir, main page]

DE60300581D1 - Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen - Google Patents

Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen

Info

Publication number
DE60300581D1
DE60300581D1 DE60300581T DE60300581T DE60300581D1 DE 60300581 D1 DE60300581 D1 DE 60300581D1 DE 60300581 T DE60300581 T DE 60300581T DE 60300581 T DE60300581 T DE 60300581T DE 60300581 D1 DE60300581 D1 DE 60300581D1
Authority
DE
Germany
Prior art keywords
perindopril
synthesis
pharmaceutically acceptable
acceptable salts
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60300581T
Other languages
English (en)
Other versions
DE60300581T2 (de
Inventor
Thierry Dubuffet
Jean-Pierre Lecouve
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Les Laboratoires Servier SAS
Original Assignee
Les Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier SAS filed Critical Les Laboratoires Servier SAS
Publication of DE60300581D1 publication Critical patent/DE60300581D1/de
Application granted granted Critical
Publication of DE60300581T2 publication Critical patent/DE60300581T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60300581T 2003-03-12 2003-03-12 Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmba- ren Salzen Expired - Lifetime DE60300581T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03290605A EP1321471B1 (de) 2003-03-12 2003-03-12 Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen

Publications (2)

Publication Number Publication Date
DE60300581D1 true DE60300581D1 (de) 2005-06-09
DE60300581T2 DE60300581T2 (de) 2006-01-19

Family

ID=8185877

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60300581T Expired - Lifetime DE60300581T2 (de) 2003-03-12 2003-03-12 Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmba- ren Salzen

Country Status (10)

Country Link
EP (1) EP1321471B1 (de)
AR (1) AR043567A1 (de)
AT (1) ATE294814T1 (de)
DE (1) DE60300581T2 (de)
DK (1) DK1321471T3 (de)
ES (1) ES2240919T3 (de)
MY (1) MY135359A (de)
PT (1) PT1321471E (de)
SI (1) SI1321471T1 (de)
WO (1) WO2004083238A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1367061T1 (sl) * 2003-06-30 2006-04-30 Servier Lab Nov postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
ATE360638T1 (de) * 2003-06-30 2007-05-15 Servier Lab Verfahren für die synthese von perindopril und seiner pharmazeutisch geeigneten salze
DK1367062T3 (da) * 2003-07-31 2007-01-02 Servier Lab Ny fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DK1380590T3 (da) * 2003-08-29 2007-01-08 Servier Lab Ny fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
SI1380591T1 (sl) 2003-08-29 2006-02-28 Servier Lab Nov postopek sinteze perindoprila in njegovih farmacevtsko sprejemljivih soli
CA2618561C (en) * 2005-08-12 2014-04-29 Lek Pharmaceuticals D.D. A process for the preparation of perindopril erbumine
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
PH12018502155B1 (en) 2016-04-20 2024-03-27 Servier Lab Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341296C (en) * 1981-12-29 2001-09-25 Hansjorg Urbach 2-azabicycloalkane-3-carboxylic acid derivatives, processes for their preparation, agents containing these compounds and their use
FR2807431B1 (fr) * 2000-04-06 2002-07-19 Adir Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
FR2827860B1 (fr) * 2001-07-24 2004-12-10 Servier Lab Nouveau procede de synthese de derives de l'acide (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxyline et application a la synthese du perindopril

Also Published As

Publication number Publication date
AR043567A1 (es) 2005-08-03
EP1321471B1 (de) 2005-05-04
SI1321471T1 (de) 2005-08-31
PT1321471E (pt) 2005-07-29
DE60300581T2 (de) 2006-01-19
DK1321471T3 (da) 2005-08-29
MY135359A (en) 2008-03-31
EP1321471A1 (de) 2003-06-25
ES2240919T3 (es) 2005-10-16
WO2004083238A1 (fr) 2004-09-30
ATE294814T1 (de) 2005-05-15

Similar Documents

Publication Publication Date Title
DE60129800D1 (de) Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salze
ATE455106T1 (de) Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen
EP1513403A4 (de) Herzglykoside für die behandlung von mukoviszidose und anderen il-8-bedingten erkrankungen
DE60318839D1 (de) 2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten
EP1730113A4 (de) Verfahren zur synthese eines cxcr4-antagonisten
DE60311942D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
DE60303101D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
DE60313391D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutisch geeigneten Salze
FR2868414B1 (fr) Procede de production d'alpha-alumine particulaire et apha-alumine particulaire produite par ce procede
ATE365714T1 (de) Verfahren zur herstellung von hochreinem perindopril und zwischenverbindungen nützlich in der synthese
DE60300581D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
DE60301820D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
DE60308102D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salzen i2003/26ö
EG24152A (en) Novel method for the synthesis of s-indoline-2-carboxylic acid and application thereof in synthesis of perindopril
DE60302287D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salzen
DE60319196D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salzen
DE60301930D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salze
DE60307925D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
DE60307721D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
DE60311730D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salzen
DE60336931D1 (de) Verfahren zur synthese der bisbenzimidazolen und ihren derivaten.
ATE534624T1 (de) Verfahren und zwischenprodukte für die herstellung von n-(1-benzhydryl-azetidin-3-yl)-n- phenyl-methylsulphonamid-derivaten
FR2861727B1 (fr) Procede de synthese directe d'alkylhalogenosilanes
DE602005020131D1 (de) Syntheseverfahren und zwischenprodukte zur herstellung von rizatriptan

Legal Events

Date Code Title Description
8364 No opposition during term of opposition